| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,022 | 19,913 | 19,583 | 17,271 | | Cost of Revenue | 5,446 | 5,072 | 5,498 | 4,519 | | | Gross Profit | 14,576 | 14,841 | 14,085 | 12,752 | | | Operating Expenses | | Research Development | 6,786 | 5,983 | 7,131 | 5,203 | | Selling General and Administrative | 14,816 | 15,967 | 14,718 | 13,227 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 371 | 354 | 407 | 362 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,397) | (7,463) | (8,171) | (6,040) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (35) | (71) | (131) | (1,477) | | Earnings Before Interest And Taxes | (7,432) | (7,534) | (8,302) | (7,517) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (7,432) | (7,534) | (8,302) | (7,517) | | Income Tax Expense | 242 | 226 | 152 | 182 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,674) | (7,760) | (8,454) | (7,699) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,674) | (7,760) | (8,454) | (7,699) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,674) | ($7,760) | ($8,454) | ($7,699) |
|
0.00% Nasdaq 
Income Statement
